News
03-24-2012, 01:12 AM
Scientists have uncovered a marker of DNA damage that could predict who will respond to platinum-based chemotherapy drugs like cisplatin or carboplatin. These drugs are widely used for ovarian cancer, but as with most cancer drugs, it can be difficult to predict who will respond to therapy...
More... (http://www.medicalnewstoday.com/releases/243273.php)
More... (http://www.medicalnewstoday.com/releases/243273.php)